| Characteristic | Never used | Used in the past, but no longer use | Currently use |
|---|---|---|---|
| Rx DMT (injectable, oral, and/or infusion/IV) | 10% | 21% | 69% |
| Rx or OTC NSaids or other pain medications (ibuprofen, aleve, etc.) | 18% | 22% | 59% |
| Complementary and alternative therapies (chiropractor, massage, yoga, vitamins, etc.) | 34% | 19% | 47% |
| Other medication or treatment not listed | 49% | 15% | 36% |
| Muscle relaxants (lioresal, valium, etc.) | 54% | 18% | 28% |
| Neuromodulators or anticonvulsants (gabapentin, klonopin, etc.) | 56% | 18% | 26% |
| Rehabilitation therapy (physical therapy, occupational therapy, etc.) | 37% | 49% | 15% |
| Ampyra (dalfampridine) | 76% | 12% | 12% |
| Chemotherapy (methotrexate, novantrone, etc.) | 90% | 9% | 2% |
| Stem cell therapy/treatment | 99% | 1% | 0.4% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
More information
Region
United States
Survey time period
2016
Number of respondents
5,040 respondents
Special properties
diagnosed with MS
Method of interview
Online survey
Supplementary notes
Original questions: "Are you currently using, or have you ever used the following types of medications or treatments for your MS or its symptoms?" - "How long have you been using your current treatment plan?" - "How likely are you to change your treatment plan in the next 12 months?"
Citation formats
